search

Active clinical trials for "Growth Hormone-Secreting Pituitary Adenoma"

Results 1-5 of 5

Modulating the GIP System in Patients With Acromegaly Due to a Pituitary Tumor

Acromegaly Due to Pituitary Adenoma

Modulation of the GIP System in Patients With Acromegaly Due to a Pituitary adenoma

Active2 enrollment criteria

Multicenter Evaluation of the Effect of Upfront Radiosurgery on Residual Growth Hormone-secreting...

Acromegaly Due to Pituitary Adenoma

In this study, the investigators hypothesize that upfront gamma knife radiosurgery with drug therapy is superior in the treatment of growth hormone-secreting pituitary tumors after primary surgical treatment compared with the drug therapy alone. This study can provide useful clinical information in the treatment of patients with acromegaly.

Unknown status9 enrollment criteria

A Pilot Study of Rosiglitazone in the Treatment of GH Secreting Pituitary Adenomas

Pituitary Tumor

Growth hormone secreting pituitary adenomas(GHomas) produce excessive GH, stimulating excessive insulin like growth factor 1(IGF-1) synthesis in the liver, thus causing multiple systemic complications. The life expectancy of patients with untreated GHomas is shortened by ten years. The treatment goal of GHomas is to shrink the tumor volume and normalize GH and IGF-1. Under current treatment, only 50-70% of patients get remission. Rosiglitazone is a widely used oral antidiabetic medicine. The investigator's preliminary data showed that rosiglitazone decreased the synthesis of GH and IGF-1 in rat pituitary tumor cells GH3 and hepatocytes respectively. The investigator plan to investigate the efficacy of rosiglitazone in the treatment of patients with GHomas who have not been alleviated by other therapies.

Unknown status14 enrollment criteria

Glycemic Fluctuations in Newly Diagnosed Growth Hormone-Secreting Pituitary Adenoma and Cushing...

Pituitary Adenoma

Glucose fluctuations present not only in patients with diabetes mellitus but also in subjects with normal glucose tolerance or impaired glucose regulation. People with Growth Hormone-Secreting Pituitary Adenoma and Cushing Syndrome are at risk of impaired glucose metabolism. Glycemic variability is poorly studied in the nondiabetic individuals. The aim of the study is to investigate the characteristics of glucose fluctuations in the newly diagnosed Growth Hormone-Secreting Pituitary Adenoma and Cushing Syndrome individuals.

Completed8 enrollment criteria

Interdisciplinary Pituitary Disorders Centre of Excellence: Assessment of Patient Education Tools...

Pituitary NeoplasmsProlactinoma3 more

The purpose of this research study is to determine the utility of educational materials designed to inform patients of their pituitary condition, in an effort to assist the patients, families, and staff deal with pituitary tumours and related conditions in the best way possible. We have developed a website, informational videos, and a brochure for pituitary tumour patients and their families. The primary outcome measures will be 1) the level of knowledge that patients have of their condition before and after reviewing the materials provided; and 2) ease of use and user satisfaction of the materials. We hypothesize that our informative multimedia educational package will not only improve the health literacy and self-efficacy of patients and their families, but will also improve quality of care.

Unknown status7 enrollment criteria
1

Need Help? Contact our team!


We'll reach out to this number within 24 hrs